DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA

Authors: Ioannis Ntafoulis, Anne Kleijn, Cassandra Posthoorn-Verheul, Stijn L W Koolen, Trisha Kers, Chelsea W J den Hollander, Jie Ju, Yunlei Li, Andrew P Stubbs, Clemens M F Dirven, Sieger Leenstra, Martine L M Lamfers

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.392

Source: Full article


Abstract

Abstract